medigraphic.com
ISSN 1561-3119 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cubana Pediatr 2013; 85 (2)

Imipramine-treated infant enuresis

Rodríguez VN,vMartínez PTP, Martínez GR, López BJ, Garriga RM

Language: Spanish
References: 16
Page: 213-220
PDF size: 63.31 Kb.


ABSTRACT

Introduction: enuresis, which is said to be the involuntary discharge of urine after the age at which the urinary control should has been achieved, that is, around 5 years-old, is a well-known disorder since ancient times. It has deserved the attention of numerous researchers but there are still very different criteria about its etiology at the present time.
Objective: to identify the effectiveness of imipramine to treat night enuresis.
Methods: one hundred and fifty children of both sexes with no previous lesions and night enuresis, who were attended at Plaza de la Revolucion teaching polyclinics, were studied. They were treated with imipramine for a year. Several variables such as age, sex, schooling, classification of enuresis, frequency of urination and sleep threshold, the latter being determined in a very subjective way, were all analyzed.
Results: the elder group of children aged 6 to 8 years, with females predominating in all the age groups. Schooling was normal in 145 children who accounted for the vast majority of the sample. Primary enuresis extensively prevailed and the most frequent forms were daily involuntary urination and once a week in the 6-8 years-old group. Almost all the patients (132) remained asleep after urination. The imipramine-based treatment was given at growing doses, according to the age, up to maximum dose of 75 mg, and proved to be effective in 48.6 % of patients, whose symptoms completely disappeared and in 28 % of them who experienced some improvement in the presentation of symptoms.
Conclusions: imipramine was effective in most of patients since the symptoms disappeared completely.


REFERENCES

  1. Nelson. Textbook of Pediatrics. 18th edition. Chapter 22. Vegetative Disorders. Neil W. Boris and Richard Dalton. Enuresis (Bed-Walting). Philadelphia: Elsevier; 2007. p. 113.

  2. Butter RJ, Golding J, Norrhstone K. ALSPAC Study Team: nocturnal enuresis at 7.5 years old. Prevalence and analysis of clinical signs. B/U lrt. 2005;96:404-10.

  3. Robson WL. Clinical practice. Evaluation and management of enuresis. N Engl J Med. 2009;360:1429-36.

  4. Berkow R, Fletcher A. The Manual Merck of Diagnosis and Therapy. 10th en español. Edición del centenario. Correspondiente a la 17 edición general. Capítulo 262. Evaluación del desarrollo. N.J.: Merck Co.; 1999. p. 2255.

  5. Hanafin S. Sociodemographic factors associated with nocturnal enuresis. Br J Nurs. 1998;7(7):403-8.

  6. Katz ER, DeMaso DR. Rumination, pica, and elimination (enuresis, encopresis) disorders. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 19th. ed. Philadelphia, Pa: Saunders Elsevier; 2011. p. 21.

  7. Weiss JP, Blaivas JG. Nocturia. J Urol. 2000;163(1):5-12.

  8. Skoog SJ. Behavior modification in the treatment of enuresis. J Urol. 1998;160(3):861-2.

  9. Daly JM, Wilens T. The use of tricyclic antidepressants in children and adolescents. Pediatr Clin North Am. 1998;45(5):1123-35.

  10. Van Zwet JM, Wiertz YD, Bolk Bennink LF, Van Leerdam FJ, Hirasing RA. Alarm training also successful in 5 to 7 years old with nocturnal enuresis. Ned Tijdschr Geneeskd. 1998;142(16):897-900.

  11. Boomsma LJ, Van der. Laan JR. Urination alarm training also successful with 5-7 years old suffering from enuresis nocturnal. Ned Tijdschr Geneeskd. 1998;142(29):1685-6.

  12. Jensen IN, Kristensen G. Alarm treatment: analyses of response and relapse. Scand J Urol Nephrol Suppl. 1999;202:73-5.

  13. Lottmann H. Enuresis treatment in France. Scand J Urol Nephrol Suppl. 1999;202:66-9.

  14. Glazener CMA, Evans JHC. Desmopresina para la enuresis nocturna en niños (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus [serie en Internet]. 2008 [citado 20 de octubre de 2012];4. Disponible en: http://www.update-software.com

  15. Kahan E, Morel D, Amir J, Zeicer C. A controlled trial of desmopressin and behavioral therapy for nocturnal enuresis. Medicine Baltimore. 1998;77(6):384-8.

  16. Karen G, Harbut RP. Hemofilias A y B. Influencia de la Desmopresina. Rev invest clin. 2007;50(54):10.




2020     |     www.medigraphic.com